Vertex makes it official: Company is staying put
Vertex Pharmaceuticals Inc., a Cambridge biotech company that once was looking to relocate to the South Boston Waterfront, has instead extended the leases for its headquarters for five years.
The company, which is developing drugs to treat hepatitis C and HIV infections, had been considering moving into a proposed office building at Fan Pier. That deal stalled late last year after the developer, Joseph F. Fallon, was unable to obtain financing for the project as a result of the credit crisis and slowing economy.
The renewed leases, which run through 2015, cover approximately 292,000 square feet at 130 Waverly St. and 200 Sidney St.
(By Erin Ailworth, Globe staff)